Hypertensive crises following platelet transfusions in a patient on erythropoietin therapy.

نویسندگان

  • F Caravaca
  • A Fernández
  • J F Barquilla
  • M Arrobas
چکیده

A marked increase in blood pressure was observed Introduction immediately after operation, needing the institution of more intensive antihypertensive therapy (Figure 1). The mechanism by which recombinant human erythroThe patient was discharged 12 days later, with her poietin (Epo) increases blood pressure in a substantial blood pressure controlled with captopril 100 mg/day. proportion of uraemic patients is still unclear. In vitro Five days later, she was readmitted for peritoneal studies support changes in endothelial function [1,2]. dialysis treatment. Her blood pressure was Increased vascular responsiveness to endogenous vaso140/80 mmHg. Because of peritoneal outflow obstrucconstrictors has also been shown in uraemic patients tion, omental wrapping of the catheter was suspected receiving Epo [3,4]. and a laparatomy was performed. One hour prior to We previously observed that antiplatelet therapy laparatomy six platelet packs were transfused, the may protect these patients from the development of patient again developing severe hypertension, which hypertension induced by Epo [5,6 ]. One hypothesis to did not respond to analgesic or anxiolytic drugs explain this finding may be the influence of hyperactive (Figure 1). platelets on the function of an abnormal endothelium. In order to rule out the influence of volume expanWe study the effect of Epo in an end-stage renal sion on the hypertensive crises following platelet transfailure patient with severe thrombocytopenia and fusions, 350 ml of saline 0.9% (the estimated plasma the changes in her blood pressure after platelet transfusions.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.

Anemia is a universal finding in patients undergoing autologous bone marrow transplantation (BMT). Effective therapies to increase the number of autologous red blood cells could result in a lower morbidity and mortality associated with red blood cell transfusions. We examined whether the addition of erythropoietin (Epo) to intensive therapy supported by progenitor cell transplantation and granu...

متن کامل

Platelet antigens and antibodies in multitransfused patients

Abstract Background and Objectives Following incompatible blood transfusions, anti-HLA and  anti- HPA antibodies may develop and cause various disorders such as post-transfusion purpura, platelet refractoriness, and thrombocytopenia leading to bleeding. The aim of this study was to investigate platelet antigens and antibodies in multi-transfused patients.   Materials and Methods In this desc...

متن کامل

RECOMBINANT ERYTHROPOIETIN AND BLOOD TRANSFUSION IN VERY LOW BIRTH WEIGHT INFANTS

 ABSTRACT Background: Very low birth weight infants ( <1500 g) frequently require blood transfusions because of repeated blood sampling accompanied by anemia of prematurity. Methods: In an attempt to identify the effect of human recombinant erythropoietin to decrease the requirement for blood transfusions, erythropoietin was administered to 24 pre term infants less than 1500 g prospectively fro...

متن کامل

Serum vitamin D level and hypertensive crises

Introduction :Vitamin D deficiency is associated with hypertension; however, there is no study on the relationship between vitamin D deficiency and hypertensive crises. This study aimed to determine the relationship between serum vitamin D levels and hypertensive crises. Materials and Methods: This descriptive-analytical, cross-sectional study was conducted on 120 individuals in Shafa Hospital ...

متن کامل

Alloimmunization following platelet transfusion: the absence of a dose-response relationship.

A major concern about the use of prophylactic platelet transfusions is the development of alloimmunization. To determine whether the rate of alloimmunization is related to the number of platelet transfusions, we measured the development of lymphocytotoxic antibody in the first 2 mo of induction therapy in patients with acute nonlymphocytic leukemia. All patients received prophylactic random don...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

دوره 12 4  شماره 

صفحات  -

تاریخ انتشار 1997